Nuvectis Pharma, Inc. (NVCT) ownership: Insider activity, 90 days: Insiders bought (0 sales, 2 open-market buys). SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Vanguard | 872638.00 | $6.75M | not in filing | 2026-03-31 |
| BlackRock | 764441.00 | $5.91M | not in filing | 2026-03-31 |
| Iridian Asset Management Llc/ct | 651757.00 | $5.04M | not in filing | 2026-03-31 |
| Occam Crest Management LP | 407147.00 | $3.15M | not in filing | 2026-03-31 |
| Geode Capital Management | 384105.00 | $2.97M | not in filing | 2026-03-31 |
| Baldwin Wealth Partners Llc/ma | 378625.00 | $2.93M | not in filing | 2026-03-31 |
| State Street | 166516.00 | $1.29M | not in filing | 2026-03-31 |
| Northern Trust | 124212.00 | $960159.00 | not in filing | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-03 | |
| Buy | null | 2026-06-30 | |
| Buy | null | 2026-06-30 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-01-06 |
Back to NVCT overview · NVCT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.